Vismodegib | List of Frontiers open access articles

Original Research

Published on 10 Nov 2020

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole

in Cancer Molecular Targets and Therapeutics

Raíza Dias Freitas
Rosane Borges Dias
Manuela Torres Andion Vidal
Ludmila de Faro Valverde
Rafaela Gomes Alves Costa
Andresa Karen Andrade Damasceno
Caroline Brandi Schlaepfer Sales
Leonardo de Oliveira Siquara da Rocha
Mitermayer Galvão dos Reis
Milena Botelho Pereira Soares

Frontiers in Oncology

doi 10.3389/fonc.2020.563838

10,018 views
22 citations

Original Research

Published on 13 Nov 2020

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis

in Skin Cancer

Maria Chiara Tronconi
Alessandra Solferino
Laura Giordano
Riccardo Borroni
Luca Mancini
Armando Santoro

Frontiers in Oncology

doi 10.3389/fonc.2020.563404

3,422 views
7 citations

Original Research

Published on 16 May 2025

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database

in Pharmacoepidemiology

Bingqing Wang
Kaidi Zhao
Ningyi Xian
Landong Ren
Jiashu Liu
Chen Tu
Dewu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1497708

4,109 views
2 citations

Original Research

Published on 04 Jun 2019

Deciphering the Allosteric Effect of Antagonist Vismodegib on Smoothened Receptor Deactivation Using Metadynamics Simulation

in Medicinal and Pharmaceutical Chemistry

Xiaoli An
Qifeng Bai
Fang Bai
Danfeng Shi
Huanxiang Liu
Xiaojun Yao

Frontiers in Chemistry

doi 10.3389/fchem.2019.00406

4,209 views
2 citations

Mini Review

Published on 14 Jun 2022

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response

in Dermatology

Donatella Gambini
Emanuela Passoni
Gianluca Nazzaro
Giada Beltramini
Gianluca Tomasello
Michele Ghidini
Elisabetta Kuhn
Ornella Garrone

Frontiers in Medicine

doi 10.3389/fmed.2022.893063

15,412 views
45 citations

Case Report

Published on 30 Jan 2025

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy

in Skin Cancer

Chalette Lambert-Swainston
Wolfram Samlowski
Brandon Reynolds
Amin Hedayat

Frontiers in Oncology

doi 10.3389/fonc.2025.1500785

2,112 views

Case Report

Published on 18 Jul 2024

Case report: Sequential treatment strategy for advanced basal cell carcinoma in Gorlin-Goltz syndrome: integration of vismodegib, radiotherapy, surgery, and high-intensity focused ultrasound

in Skin Cancer

Jacek Calik
Małgorzata Oślizło
Beata Słocka-Romaniuk
Ahmed Elsaftawy
Natalia Sauer

Frontiers in Oncology

doi 10.3389/fonc.2024.1428702

2,869 views
4 citations

Review

Published on 30 Jul 2025

Sonic Hedgehog signaling in spinal cord injury: mechanisms and therapeutic implications

in Molecular Signalling and Pathways

Mingjuan Du
Xiaozhen Ji
Weiting Chen

Frontiers in Molecular Neuroscience

doi 10.3389/fnmol.2025.1624501

4,326 views
3 citations

Review

Published on 09 Feb 2023

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer

in Dermatology

Marco Rubatto
Nadia Sciamarrelli
Silvia Borriello
Valentina Pala
Luca Mastorino
Luca Tonella
Simone Ribero
Pietro Quaglino

Frontiers in Medicine

doi 10.3389/fmed.2022.959289

11,953 views
29 citations

Articles

Inhibition of CAL27 Oral Squamous Carcinoma Cell by Targeting Hedgehog Pathway With Vismodegib or Itraconazole

Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis

Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database

Deciphering the Allosteric Effect of Antagonist Vismodegib on Smoothened Receptor Deactivation Using Metadynamics Simulation

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response

Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapy

Case report: Sequential treatment strategy for advanced basal cell carcinoma in Gorlin-Goltz syndrome: integration of vismodegib, radiotherapy, surgery, and high-intensity focused ultrasound

Sonic Hedgehog signaling in spinal cord injury: mechanisms and therapeutic implications

Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer